Galiste, Lesheen .
HRN: 16-66-40 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
CEFUROXIME 750MG (VIAL)
04/01/2024
04/07/2024
IV
750mg
Q8hrs
Uti
Checking Final Appropriateness